Clinical trial
A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma
NCT06809647 is registered in ClinicalTrials.gov with PLU Ophthalmic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma
- Lead sponsor
- PLU Ophthalmic
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 30, 2025
- Completion date
- August 30, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma open-angle